The biotech startups market was valued at USD 36.5 billion in 2024 and is projected to grow at a CAGR of 15.4% from 2025 to 2030. This market encompasses innovative solutions and funding opportunities in the biotechnology sector, facilitating advancements in healthcare.
Product Insights
Innovative solutions accounted for the largest share of the market in 2024, contributing 65.4% of total revenue. Biotech startups are focusing on developing cutting-edge therapies and technologies, driving innovation in the healthcare landscape.
End-Use Insights
Investors represented the largest end-use segment, capturing 58.2% of the market share, as they seek opportunities in the rapidly evolving biotech industry. Entrepreneurs are also increasingly entering the market, supported by growing interest in biotechnology investments.
Regional Insights
North America dominated the biotech startups market with a 54.3% share in 2024, fueled by a strong venture capital ecosystem and extensive research activities. The Asia Pacific region is expected to witness significant growth, with a CAGR of 16.7%, as startups emerge in various countries.